AU684087B2 - Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin - Google Patents

Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin Download PDF

Info

Publication number
AU684087B2
AU684087B2 AU70760/94A AU7076094A AU684087B2 AU 684087 B2 AU684087 B2 AU 684087B2 AU 70760/94 A AU70760/94 A AU 70760/94A AU 7076094 A AU7076094 A AU 7076094A AU 684087 B2 AU684087 B2 AU 684087B2
Authority
AU
Australia
Prior art keywords
document
date
modafinil
cited
documents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU70760/94A
Other languages
English (en)
Other versions
AU7076094A (en
Inventor
Philippe Laurent
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Sante SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9448411&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU684087(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Publication of AU7076094A publication Critical patent/AU7076094A/en
Application granted granted Critical
Publication of AU684087B2 publication Critical patent/AU684087B2/en
Assigned to TEVA SANTE reassignment TEVA SANTE Request to Amend Deed and Register Assignors: LABORATOIRE L. LAFON
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Control Of Throttle Valves Provided In The Intake System Or In The Exhaust System (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU70760/94A 1993-06-22 1994-06-14 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin Expired AU684087B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9307555 1993-06-22
FR9307555A FR2706767B1 (enExample) 1993-06-22 1993-06-22
PCT/FR1994/000711 WO1995000132A1 (fr) 1993-06-22 1994-06-14 Utilisation du modafinil pour le traitement des apnees du sommeil et troubles ventilatoires d'origine centrale

Publications (2)

Publication Number Publication Date
AU7076094A AU7076094A (en) 1995-01-17
AU684087B2 true AU684087B2 (en) 1997-12-04

Family

ID=9448411

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70760/94A Expired AU684087B2 (en) 1993-06-22 1994-06-14 Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin

Country Status (14)

Country Link
US (1) US5612379A (enExample)
EP (1) EP0705099B1 (enExample)
JP (1) JP3703831B2 (enExample)
KR (1) KR100315389B1 (enExample)
AT (1) ATE207351T1 (enExample)
AU (1) AU684087B2 (enExample)
CA (1) CA2165824C (enExample)
DE (1) DE69428791T2 (enExample)
DK (1) DK0705099T3 (enExample)
ES (1) ES2165878T3 (enExample)
FR (1) FR2706767B1 (enExample)
HU (1) HU216731B (enExample)
PT (1) PT705099E (enExample)
WO (1) WO1995000132A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
JP2002504510A (ja) 1998-02-27 2002-02-12 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティ オブ イリノイ 睡眠時無呼吸に対する処置のための、セロトニン関連活性を有する薬剤
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
US6492396B2 (en) 2000-05-16 2002-12-10 Cephalon, Inc. Substituted thioacetamides
JP4593074B2 (ja) * 2000-10-11 2010-12-08 セフアロン・インコーポレーテツド モダフィニル化合物含有組成物
US20080058424A1 (en) * 2002-05-23 2008-03-06 Cephalon, Inc. Novel pharmaceutical formulations of modafinil
US7297346B2 (en) * 2001-05-25 2007-11-20 Cephalon Inc. Pharmaceutical formulations of modafinil
US7229644B2 (en) * 2002-05-23 2007-06-12 Cephalon, Inc. Pharmaceutical formulations of modafinil
US20040048931A1 (en) 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
US20040116532A1 (en) * 2002-09-13 2004-06-17 Craig Heacock Pharmaceutical formulations of modafinil
IL153098A0 (en) * 2002-11-26 2003-06-24 Chemagis Ltd Pharmaceutical compositions containing modafinil
US7528172B2 (en) * 2003-01-21 2009-05-05 The Cooper Health System, Inc. Compositions and methods for improving recovery after general anesthesia
ES2487415T3 (es) * 2003-03-17 2014-08-20 Neurohealing Pharmaceuticals, Inc. Tratamiento dopaminérgico de alta potencia de deficiencias neurológicas asociadas con lesiones cerebrales
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
EP1586560A1 (en) * 2004-04-13 2005-10-19 Cephalon, Inc. Thio-substituted arylmethanesulfinyl derivatives
US7423176B2 (en) * 2004-04-13 2008-09-09 Cephalon, Inc. Bicyclic aromatic sulfinyl derivatives
US7449481B2 (en) * 2004-04-13 2008-11-11 Cephalon, Inc. Thio-substituted biaryl-methanesulfinyl derivatives
US7314875B2 (en) * 2004-04-13 2008-01-01 Cephalon, Inc. Tricyclic aromatic and bis-phenyl sulfinyl derivatives
US7297817B2 (en) * 2004-04-13 2007-11-20 Cephalon France Thio-substituted arylmethanesulfinyl derivatives
WO2006069030A1 (en) * 2004-12-20 2006-06-29 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
AU2006272874B2 (en) * 2005-07-21 2010-03-11 Neurohealing Pharmaceuticals, Inc. Rapid onset and short term modafinil compositions and methods of use thereof
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
JP5395663B2 (ja) 2006-08-14 2014-01-22 ニューロヒーリング・ファーマシューティカルズ・インコーポレーテッド モダフィニルによる早漏の治療
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
CN101641090B (zh) * 2006-12-19 2012-12-05 亚勒斯有限公司 莫达非尼在制备治疗多动腿综合征的药物中的应用
AU2011203970A1 (en) * 2010-01-07 2012-07-12 Vivus, Inc. Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent
ES2871381T3 (es) 2013-08-30 2021-10-28 Green Cross Wellbeing Corp Composición para prevenir y tratar la fatiga relacionada con el cáncer, que contiene polvo de ginseng procesado o extracto de ginseng procesado que tiene un componente de ginsenósido mejorado
US9616068B2 (en) 2014-10-27 2017-04-11 Pohela LLC Animal training using cognitive enhancement

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584462A (en) * 1977-03-31 1981-02-11 Lafon Labor N-diaryl-malonamide and diarylmethyl-sulphinyl-acetamide derivatives and pharmaceutical compositions containing them
FR2663225B1 (fr) * 1990-06-14 1994-11-04 Lafon Labor Nouvelle utilisation du modafinil.
FR2684875B1 (fr) * 1991-12-13 1995-05-24 Lafon Labor Utilisation du modafinil pour la fabrication d'un medicament ayant un effet anti-ischemique.
US5281607B1 (en) * 1992-10-08 1998-05-19 Univ New York Method of using alpha 2-antagonists for the treatment of neurodegenerative diseases

Also Published As

Publication number Publication date
ATE207351T1 (de) 2001-11-15
KR100315389B1 (ko) 2002-02-19
JP3703831B2 (ja) 2005-10-05
WO1995000132A1 (fr) 1995-01-05
CA2165824C (fr) 2005-08-02
KR960703009A (ko) 1996-06-19
PT705099E (pt) 2002-03-28
AU7076094A (en) 1995-01-17
CA2165824A1 (fr) 1995-01-05
DE69428791D1 (de) 2001-11-29
EP0705099A1 (fr) 1996-04-10
EP0705099B1 (fr) 2001-10-24
JPH09500374A (ja) 1997-01-14
HU216731B (hu) 1999-08-30
ES2165878T3 (es) 2002-04-01
FR2706767A1 (enExample) 1994-12-30
DE69428791T2 (de) 2002-07-04
HUT74674A (en) 1997-01-28
US5612379A (en) 1997-03-18
HU9503702D0 (en) 1996-02-28
DK0705099T3 (da) 2002-02-11
FR2706767B1 (enExample) 1995-09-08

Similar Documents

Publication Publication Date Title
AU684087B2 (en) Use of modafinil for the treatment of sleep apnoea and ventilation problems of central origin
Taranto-Montemurro et al. The combination of atomoxetine and oxybutynin greatly reduces obstructive sleep apnea severity. A randomized, placebo-controlled, double-blind crossover trial
Becker et al. Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure.
Pagel et al. Medications for the treatment of sleep disorders: an overview
Mamelak et al. Treatment of narcolepsy and sleep apnea with gammahydroxybutyrate: a clinical and polysomnographic case study
JPS62111924A (ja) 恐慌障害の軽減剤
Walton et al. Ketorolac and diclofenac for postoperative pain relief following oral surgery
DE60111025T2 (de) Verwendung von Topiramat zur Behandlung und Diagnostizierung von Atemstörungen während des Schlafens und Mittel zur Durchführung der Behandlung und Diagnose
Zhu et al. Dental management of children with asthma
Baghani et al. The dental management of the asthmatic patients
Buckle et al. Nocturnal cluster headache associated with sleep apnea. A case report
JP2501033B2 (ja) Ｄ―フェンフルラミン含有うつ病用医薬組成物
Goold Postoperative spasticity and shivering: a review with personal observations of 500 patients
DE60100660T2 (de) Verwendung von modafinil zur herstellung eines arzneimittels zur behandlung von vigilanzstörungen im zusammenhang mit myopathien
Oham et al. Subcutaneous ketamine prolongs the analgesic effect of local infiltration of plain Bupivacaine in children undergoing inguinal herniotomy
JPH08512311A (ja) 慢性疲労症候群治療用ヒ素医薬
Castillo et al. Effectiveness of mirtazapine in the treatment of sleep apnea/hypopnea syndrome (SAHS)
CN1395487A (zh) 米氮平用于治疗睡眠障碍的用途
Hou et al. Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial
Kim et al. Transdermal scopolamine alters phasic REM activity in normal young adults
Aronson Meyler's side effects of drugs used in anesthesia
Rhodes et al. A comparison of the effects of zolpidem and placebo on respiration and oxygen saturation during sleep in the healthy elderly.
Weksler et al. Lidocaine pretreatment effectively decreases the incidence of hiccups during methohexitone administration for dilatation and curettage
Owens et al. Nebulized atropine sulfate in the treatment of acute asthma
Bachrach et al. Clinical observations on the use of alphaprodine (nisentil) for postoperative analgesia